ROSENBLUM MARK J (Exec VP Finance, Interim CFO) received a stock award from DECOY THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/2/2026ACC: 0001329154-26-000003
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+9.68K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
9.68K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+9.68K
Price / share
—
Trade value
—
% of position
576.0%
8/31/2026
1.68K→11.36K
Total
Net shares
+9.68K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2026 | A · Award | +9.68K | — | — | 576.0% | 1.68K | 11.36K |
| Total | +9.68K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported